GlassScriptPhysician profile
Brian Edward Buchanan
NPI 1689617011
$10,477.59
in general payments reported to CMS, 2019-2025
12 companies · $289 in 2025
The $289 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,332 · 2020: $215 · 2021: $708 · 2022: $1,340 · 2023: $234 · 2024: $360 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $882.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,910.30 | 2019 | |
| Medwest Associates | $2,526.84 | 2019-2023 | |
| Wright Medical Technology, INC. | $1,215.43 | 2019-2020 | |
| Stryker Corporation | $996.47 | 2021-2025 | Prostep, Ortholoc 2 Lapifuse, Actishield |
| Paragon 28, INC. | $277.78 | 2019-2023 | Portfolio, Mini Monster |
| Abbott Laboratories | $140.20 | 2021-2022 | |
| Globus Medical, INC. | $112.89 | 2021 | |
| Polynovo North America LLC | $112.47 | 2025 | Novosorb Btm |
| Vericel Corporation | $96.00 | 2021 | |
| Orthofix Medical, INC. | $56.21 | 2019-2025 | Physio-Stim |
| Davol INC. | $21.12 | 2021 | |
| Kerecis Limited | $11.88 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Buchanan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.